SambaNova AI Chip Startup Secures $1 Billion Investment, Reaching $11 Billion Valuation
Money

SambaNova AI Chip Startup Secures $1 Billion Investment, Reaching $11 Billion Valuation

authorBy Dave Ramsey
DateJul 08, 2026
Read Time3 min

SambaNova, a prominent artificial intelligence chip startup, has successfully concluded a significant funding round, securing $1 billion in investment. This latest capital injection, led by General Atlantic, propels the company's valuation to an impressive $11 billion, underscoring strong investor confidence in its innovative AI solutions. This financial milestone will enable SambaNova to accelerate its global expansion, scale its operational capabilities, and continue pushing the boundaries of AI technology through advanced research and development in chips, systems, and software infrastructure.

The Series F funding round saw substantial contributions from key investors including Seligman Ventures, T. Rowe Price Associates, and Capital Group. Additionally, both new and existing stakeholders, such as A&E Investment, Assam Ventures, funds and accounts managed by BlackRock, Intel Capital, and the Qatar Investment Authority, participated, further solidifying SambaNova's financial backing. The company's core business revolves around developing specialized chips, hardware systems, and cloud services specifically designed for AI inference, a critical process where AI models generate responses to user queries. A notable endorsement of SambaNova's technology comes from JPMorgan Chase, which has chosen the company as its inference infrastructure partner, deploying its SN40 and SN50 systems to bolster its AI capabilities.

This substantial investment follows a series of strategic financial activities for SambaNova. In February, the company raised $350 million, earmarking the funds for the expansion of its SN50 AI chip and forging a crucial partnership with Intel. This collaboration aimed to deliver cost-effective inference solutions for AI-native enterprises. The partnership included a $35 million investment from Intel into SambaNova, which received U.S. antitrust clearance in May, after initial acquisition discussions between the two companies reached an impasse. Corporate records from April indicated Intel's intention to further invest $15 million, potentially increasing its stake in SambaNova to 9%. The company, however, has not yet publicly commented on the current specifics of Intel's ownership or its contribution to the latest Series F round.

Looking back, SambaNova previously secured $676 million in a funding round in April 2021, spearheaded by SoftBank Group's Vision Fund 2, which then valued the company at over $5 billion. The consistent influx of capital highlights the growing demand for advanced AI processing capabilities and the perceived leadership of SambaNova in this rapidly evolving sector. The company is poised to utilize these new resources to enhance its offerings, broaden its market reach, and further its mission of delivering cutting-edge AI infrastructure to a diverse global clientele.

This recent capital infusion positions SambaNova to significantly scale its operations and technological advancements. The funds are earmarked for increasing production capacity, expanding global deployment efforts, and deepening investments across its entire AI ecosystem, encompassing chips, systems, software, and comprehensive full-stack AI infrastructure solutions for its customers. The strategic partnerships and robust financial backing underscore the company's ambition to remain at the forefront of the AI hardware and services industry, particularly in delivering high-performance and efficient inference solutions.

More Articles
Money
Top "Moonshot" Investments Beyond SpaceX
This article explores three promising growth stocks—IonQ, SoundHound AI, and UiPath—as alternative "moonshot" investments to SpaceX. It delves into IonQ's leadership in quantum computing accuracy, SoundHound AI's strategic move into customer service through its acquisition of LivePerson, and UiPath's potential as an agentic AI orchestration leader. The piece highlights the unique technological advancements and market opportunities each company presents, offering investors insights into high-growth, high-risk ventures in cutting-edge industries.
By Bola SokunbiJul 08, 2026
Money
Top Growth Stocks for Enduring Portfolios
This article highlights three prominent technology companies—Nvidia, Microsoft, and Meta Platforms—as strong candidates for long-term investment. It emphasizes their entrenched market positions, significant growth potential, and strategic advancements in artificial intelligence (AI), suggesting that these companies possess the qualities needed for sustained success in dynamic market conditions.
By Ramit SethiJul 08, 2026
Money
Abu Dhabi Royal Family Invests Over $1 Billion in MidOcean Energy for Global LNG Expansion
The Private Department of Abu Dhabi's Crown Prince Sheikh Mohammed bin Khalid Al Nahyan has committed a substantial $1.13 billion investment to MidOcean Energy, a US-based liquefied natural gas (LNG) company managed by EIG. This strategic move marks the Private Department's entry into the global LNG sector and initiates a broader collaboration with EIG, focusing on capital aggregation, investment sourcing, and developing institutional investment opportunities across the UAE and other regional markets. The partnership aims to enhance MidOcean Energy's shareholder base and expand its LNG portfolio.
By T. Harv EkerJul 08, 2026
Money
Bitcoin's Dividend Sustainability: Saylor's Optimism vs. Critics' Concerns
Michael Saylor, co-founder of Strategy Inc., asserts that Bitcoin's capital gains can perpetually fund preferred stock dividends if BTC appreciates over 3.3% annually. This perspective, however, faces significant opposition from critics like Peter Schiff and Ali Martinez, who highlight the volatile nature of Bitcoin's returns and the potential for increasing dividend obligations. The debate underscores fundamental disagreements on the long-term financial viability of leveraging cryptocurrency for consistent corporate payouts.
By Natalie PaceJul 08, 2026
Money
Biotech Sector Poised for Acquisition Surge, According to Jim Cramer
Jim Cramer predicts a significant increase in biotech mergers and acquisitions, driven by a more favorable regulatory landscape. Major players like Eli Lilly and Gilead are already making substantial acquisitions, while companies with proven drug data, such as Vertex and Regeneron, are becoming prime targets. This shift signals a new era of growth and investment opportunities in the biotech market, following a period of subdued deal-making.
By Scott PapeJul 07, 2026